Foscavir Injection, Solution
NDC Package 76310-024-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Foscavir (foscarnet sodium) injection is fOSCAVIR is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium. This formulation utilizes a injection, solution delivery system. Marketed by Clinigen Limited, this product is identified by NDC 76310-024 and is authorized under FDA application NDA020068.

Identification & Billing

NDC Package Code
76310-024-45
Package Description
10 POUCH in 1 CARTON / 1 BAG in 1 POUCH (76310-024-41) / 250 mL in 1 BAG
Product Code
11-Digit Billing Format
76310002445
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Foscavir
Non-Proprietary Name
Foscarnet Sodium
Substance Name
Foscarnet Sodium
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
Usage Information
FOSCAVIR is contraindicated in patients with clinically significant hypersensitivity to foscarnet sodium.

Regulatory & Marketing

Labeler Name
Clinigen Limited
Product Type
Human Prescription Drug
FDA Application #
NDA020068
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-09-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (76310-024). Click a package code to view its specific billing and regulatory data.

10 CARTON in 1 CARTON / 1 BOTTLE in 1 CARTON (76310-024-11) / 250 mL in 1 BOTTLE
10 CARTON in 1 CARTON / 1 BOTTLE in 1 CARTON (76310-024-15) / 250 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76310-024-45 identifies a specific commercial package of 10 pouch in 1 carton / 1 bag in 1 pouch (76310-024-41) / 250 ml in 1 bag of Foscavir, a human prescription drug labeled by Clinigen Limited. This injection, solution is formulated for intravenous use and contains foscarnet sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Clinigen Limited on July 09, 2012. The current certification is valid through December 31, 2026.

How is this Clinigen Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76310002445. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76310-024-45
11-Digit CMS (5-4-2)
76310-0024-45

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.